Three out of five CEOs of pharmaceutical companies pointed to "strengthening sales and marketing capabilities" as the most important management strategy to expand competitiveness in the post-Corona era. The view is that it is urgent to establish an effective sales strategy due to rapid changes in the market environment. More than half of the respondents said they should focus on expanding R&D capabilities. More than 70% of CEOs of pharmaceutical companies judged that the prolonged COVID-19 crisis had a negative impact on the company's performance.

According to Dailypharm's 2022 management strategy survey of 51 CEOs of pharmaceutical companies on the 3rd, 62.7% of respondents cited "strengthening sales a